Silence Therapeutics (SLN) Payables (2018 - 2026)
Silence Therapeutics recorded quarterly Payables of $10.4 million in Q1 2026, down 22.38% quarter-over-quarter from $13.4 million in Q4 2025, and down 44.89% year-over-year from $18.8 million in Q1 2025.
Silence Therapeutics' Payables history runs 9 years deep, the most recent figure standing at $10.4 million for Q1 2026.
- In Q1 2026, Payables fell 44.89% year-over-year to $10.4 million; the TTM figure through Mar 2026 stood at $10.4 million (down 44.89% YoY), while the FY2025 annual figure was $13.4 million, down 18.56% from the prior year.
- Payables came in at $10.4 million for Q1 2026 at Silence Therapeutics, down from $13.4 million in the prior quarter.
- In the past five years, Payables ranged from a high of $18.8 million in Q1 2025 to a low of -$18.9 million in Q2 2024.
- A 5-year average of -$2.9 million and a median of -$13.3 million in 2024 frame the typical range for Payables.
- Across the five-year window, Payables sank 204.11% in 2023 and jumped 241.41% in 2025, its largest moves.
- Silence Therapeutics' Payables stood at $14.8 million in 2022, then tumbled by 204.11% to -$15.4 million in 2023, then soared by 206.31% to $16.4 million in 2024, then dropped by 18.56% to $13.4 million in 2025, then decreased by 22.38% to $10.4 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $10.4 million, $13.4 million, and $17.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Silence Therapeutics | 924.61 Mn | 854.53 Mn | 411,000.00 | 10.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.37 Mn |
| Dec 31, 2025 | 13.36 Mn |
| Sep 30, 2025 | 16.99 Mn |
| Jun 30, 2025 | 14.31 Mn |
| Mar 31, 2025 | 18.81 Mn |
| Dec 31, 2024 | 16.40 Mn |
| Sep 30, 2024 | -18.54 Mn |
| Jun 30, 2024 | -18.92 Mn |
| Mar 31, 2024 | -13.30 Mn |
| Dec 31, 2023 | -15.43 Mn |
| Sep 30, 2023 | -15.13 Mn |
| Jun 30, 2023 | -15.26 Mn |
| Mar 31, 2023 | -16.10 Mn |
| Dec 31, 2022 | 14.82 Mn |
| Sep 30, 2022 | -17.45 Mn |
| Jun 30, 2022 | -14.73 Mn |
| Mar 31, 2022 | -10.31 Mn |
| Dec 31, 2021 | 14.54 Mn |
| Sep 30, 2021 | -12.73 Mn |
| Jun 30, 2021 | -11.00 Mn |
| Dec 31, 2020 | 10.82 Mn |
| Jun 30, 2020 | -5.85 Mn |
| Dec 31, 2019 | 8.86 Mn |
| Jun 30, 2019 | -3.68 Mn |
| Dec 31, 2018 | 4.93 Mn |